Protocol for the <it><ul>S</ul></it>moking, <it><ul>N</ul></it>icotine <it><ul>a</ul></it>nd <it><ul>P</ul></it>regnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy

<p>Abstract</p> <p>Background</p> <p>Smoking in pregnancy remains a public health challenge. Nicotine replacement therapy (NRT) is effective for smoking cessation in non-pregnant people, but because women metabolise nicotine and cotinine much faster in pregnancy, it is...

Full description

Bibliographic Details
Main Authors: Coughtrie Michael WH, Watts Kim, Lewis Sarah, Britton John, Thornton Jim, Coleman Tim, Mannion Clare, Marlow Neil, Godfrey Christine
Format: Article
Language:English
Published: BMC 2007-01-01
Series:BMC Health Services Research
Online Access:http://www.biomedcentral.com/1472-6963/7/2
_version_ 1818068153793511424
author Coughtrie Michael WH
Watts Kim
Lewis Sarah
Britton John
Thornton Jim
Coleman Tim
Mannion Clare
Marlow Neil
Godfrey Christine
author_facet Coughtrie Michael WH
Watts Kim
Lewis Sarah
Britton John
Thornton Jim
Coleman Tim
Mannion Clare
Marlow Neil
Godfrey Christine
author_sort Coughtrie Michael WH
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Smoking in pregnancy remains a public health challenge. Nicotine replacement therapy (NRT) is effective for smoking cessation in non-pregnant people, but because women metabolise nicotine and cotinine much faster in pregnancy, it is unclear whether this will be effective for smoking cessation in pregnancy. The NHS Health Technology Assessment Programme (HTA)-funded smoking, nicotine and pregnancy (SNAP) trial will investigate whether or not nicotine replacement therapy (NRT) is effective, cost-effective and safe when used for smoking cessation by pregnant women.</p> <p>Methods/Design</p> <p>Over two years, in 5 trial centres, 1050 pregnant women who are between 12 and 24 weeks pregnant will be randomised as they attend hospital for ante-natal ultrasound scans. Women will receive either nicotine or placebo transdermal patches with behavioural support. The primary outcome measure is biochemically-validated, self-reported, prolonged and total abstinence from smoking between a quit date (defined before randomisation and set within two weeks of this) and delivery. At six months after childbirth self-reported maternal smoking status will be ascertained and two years after childbirth, self-reported maternal smoking status and the behaviour, cognitive development and respiratory symptoms of children born in the trial will be compared in both groups.</p> <p>Discussion</p> <p>This trial is designed to ascertain whether or not standard doses of NRT (as transdermal patches) are effective and safe when used for smoking cessation during pregnancy.</p>
first_indexed 2024-12-10T15:35:03Z
format Article
id doaj.art-2ab9737d3dbe4d36bf057ec5a993e0ea
institution Directory Open Access Journal
issn 1472-6963
language English
last_indexed 2024-12-10T15:35:03Z
publishDate 2007-01-01
publisher BMC
record_format Article
series BMC Health Services Research
spelling doaj.art-2ab9737d3dbe4d36bf057ec5a993e0ea2022-12-22T01:43:15ZengBMCBMC Health Services Research1472-69632007-01-0171210.1186/1472-6963-7-2Protocol for the <it><ul>S</ul></it>moking, <it><ul>N</ul></it>icotine <it><ul>a</ul></it>nd <it><ul>P</ul></it>regnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancyCoughtrie Michael WHWatts KimLewis SarahBritton JohnThornton JimColeman TimMannion ClareMarlow NeilGodfrey Christine<p>Abstract</p> <p>Background</p> <p>Smoking in pregnancy remains a public health challenge. Nicotine replacement therapy (NRT) is effective for smoking cessation in non-pregnant people, but because women metabolise nicotine and cotinine much faster in pregnancy, it is unclear whether this will be effective for smoking cessation in pregnancy. The NHS Health Technology Assessment Programme (HTA)-funded smoking, nicotine and pregnancy (SNAP) trial will investigate whether or not nicotine replacement therapy (NRT) is effective, cost-effective and safe when used for smoking cessation by pregnant women.</p> <p>Methods/Design</p> <p>Over two years, in 5 trial centres, 1050 pregnant women who are between 12 and 24 weeks pregnant will be randomised as they attend hospital for ante-natal ultrasound scans. Women will receive either nicotine or placebo transdermal patches with behavioural support. The primary outcome measure is biochemically-validated, self-reported, prolonged and total abstinence from smoking between a quit date (defined before randomisation and set within two weeks of this) and delivery. At six months after childbirth self-reported maternal smoking status will be ascertained and two years after childbirth, self-reported maternal smoking status and the behaviour, cognitive development and respiratory symptoms of children born in the trial will be compared in both groups.</p> <p>Discussion</p> <p>This trial is designed to ascertain whether or not standard doses of NRT (as transdermal patches) are effective and safe when used for smoking cessation during pregnancy.</p>http://www.biomedcentral.com/1472-6963/7/2
spellingShingle Coughtrie Michael WH
Watts Kim
Lewis Sarah
Britton John
Thornton Jim
Coleman Tim
Mannion Clare
Marlow Neil
Godfrey Christine
Protocol for the <it><ul>S</ul></it>moking, <it><ul>N</ul></it>icotine <it><ul>a</ul></it>nd <it><ul>P</ul></it>regnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy
BMC Health Services Research
title Protocol for the <it><ul>S</ul></it>moking, <it><ul>N</ul></it>icotine <it><ul>a</ul></it>nd <it><ul>P</ul></it>regnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy
title_full Protocol for the <it><ul>S</ul></it>moking, <it><ul>N</ul></it>icotine <it><ul>a</ul></it>nd <it><ul>P</ul></it>regnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy
title_fullStr Protocol for the <it><ul>S</ul></it>moking, <it><ul>N</ul></it>icotine <it><ul>a</ul></it>nd <it><ul>P</ul></it>regnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy
title_full_unstemmed Protocol for the <it><ul>S</ul></it>moking, <it><ul>N</ul></it>icotine <it><ul>a</ul></it>nd <it><ul>P</ul></it>regnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy
title_short Protocol for the <it><ul>S</ul></it>moking, <it><ul>N</ul></it>icotine <it><ul>a</ul></it>nd <it><ul>P</ul></it>regnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy
title_sort protocol for the it ul s ul it moking it ul n ul it icotine it ul a ul it nd it ul p ul it regnancy snap trial double blind placebo randomised controlled trial of nicotine replacement therapy in pregnancy
url http://www.biomedcentral.com/1472-6963/7/2
work_keys_str_mv AT coughtriemichaelwh protocolfortheitulsulitmokingitulnuliticotineitulaulitnditulpulitregnancysnaptrialdoubleblindplaceborandomisedcontrolledtrialofnicotinereplacementtherapyinpregnancy
AT wattskim protocolfortheitulsulitmokingitulnuliticotineitulaulitnditulpulitregnancysnaptrialdoubleblindplaceborandomisedcontrolledtrialofnicotinereplacementtherapyinpregnancy
AT lewissarah protocolfortheitulsulitmokingitulnuliticotineitulaulitnditulpulitregnancysnaptrialdoubleblindplaceborandomisedcontrolledtrialofnicotinereplacementtherapyinpregnancy
AT brittonjohn protocolfortheitulsulitmokingitulnuliticotineitulaulitnditulpulitregnancysnaptrialdoubleblindplaceborandomisedcontrolledtrialofnicotinereplacementtherapyinpregnancy
AT thorntonjim protocolfortheitulsulitmokingitulnuliticotineitulaulitnditulpulitregnancysnaptrialdoubleblindplaceborandomisedcontrolledtrialofnicotinereplacementtherapyinpregnancy
AT colemantim protocolfortheitulsulitmokingitulnuliticotineitulaulitnditulpulitregnancysnaptrialdoubleblindplaceborandomisedcontrolledtrialofnicotinereplacementtherapyinpregnancy
AT mannionclare protocolfortheitulsulitmokingitulnuliticotineitulaulitnditulpulitregnancysnaptrialdoubleblindplaceborandomisedcontrolledtrialofnicotinereplacementtherapyinpregnancy
AT marlowneil protocolfortheitulsulitmokingitulnuliticotineitulaulitnditulpulitregnancysnaptrialdoubleblindplaceborandomisedcontrolledtrialofnicotinereplacementtherapyinpregnancy
AT godfreychristine protocolfortheitulsulitmokingitulnuliticotineitulaulitnditulpulitregnancysnaptrialdoubleblindplaceborandomisedcontrolledtrialofnicotinereplacementtherapyinpregnancy